BAY 2666605 Catalog No.:M33627-C C2HF3O2/c1-19(2)25(41-31(47)48-18-20-9-4-3-5-10-20)27(45)40-22(12-7-15-38-30(35)36)28(46)42-16-8-13-23(42)26(44)39-21(24(43)17-32)11-6-14-37-29(33)34

C2HF3O2/c1-19(2)25(41-31(47)48-18-20-9-4-3-5-10-20)27(45)40-22(12-7-15-38-30(35)36)28(46)42-16-8-13-23(42)26(44)39-21(24(43)17-32)11-6-14-37-29(33)34

possesses promising antischistosomal properties

) treatment shows the T1/2

InChi: InChI=1S/C40H56O22/c1-18(2)11-40(62-38-35(53)32(50)29(47)25(15-43)61-38

BAY 2666605 Catalog No.:M33627-C C2HF3O2/c1-19(2)25(41-31(47)48-18-20-9-4-3-5-10-20)27(45)40-22(12-7-15-38-30(35)36)28(46)42-16-8-13-23(42)26(44)39-21(24(43)17-32)11-6-14-37-29(33)34BAY 2666605 is an orally active PDE3A and PDE3B inhibitor with IC50s of 87 nM and 50 nM, respectively. BAY 2666605 is a PDE3A SLFN12 complex inducer (WO2019025562A1; example 135). Product information CAS Number: 2275774 60 0 Molecular Weight: 352. 28 Formula: C17H12F4N2O2 Smiles: C[C@@H]1OC(=O)NN=C1C1=CC(=C(C=C1)C1=CC=C(F)C=C1)C(F)(F)F InChiKey: JNTJTCXFIXNXDV VIFPVBQESA N InChi: InChI=1S C17H12F4N2O2 c1 9 15(22 23 16(24)25 9)11 4 7 13(14(8